Radiology, Vol 191, 461-465, Copyright © 1994 by Radiological Society of North America

ARTICLES

Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress

WE Drane, FD Abbott, MW Nicole, ST Mastin and JH Kuperus
Division of Nuclear Medicine, Shands Hospital, Gainesville, FL.

PURPOSE: At the time of the co-development of a commercial dual-headed gamma camera for whole-body single photon emission computed tomography (SPECT), modifications were made to permit imaging of 511-keV photons (from positron emitters) while maintaining versatility and cost- effectiveness in nuclear medicine for routine nonpositron studies. MATERIALS AND METHODS: Special collimators were made, and gantry stability was increased. Detector shielding and crystal thickness were not changed. In phantoms, healthy volunteers (two men, aged 34 and 38 years), and 109 patients (71 male and 38 female patients, aged 2-74 years [mean, 56 years]), SPECT was performed with 2-[fluorine-18]fluoro- 2-deoxy-D-glucose (FDG). In patients, 36 myocardial viability, 47 oncologic, and 26 brain examinations were performed. RESULTS: All FDG SPECT scans were subjectively judged to be of acceptable quality. Preliminary results in regard to diagnostic findings are reviewed; this analysis is intended to be a feasibility study not a conclusive review of imaging accuracy. CONCLUSION: FDG SPECT provides images that are interpretable for cardiac or oncologic diagnosis, without the need for or expense of a positron emission tomography (PET) center or a dedicated PET scanner.

This article has been cited by other articles:

				D. Delbeke, W. H. Martin, J. A. Patton, and M. P. Sandler Value of Iterative Reconstruction,AttenuationCorrection,and Image Fusion in the Interpretation of FDG PET Images with an Integrated Dual-Head Coincidence Camera and X-Ray-based Attenuation Maps Radiology, January 1, 2001; 218(1): 163 - 171. [Abstract] [Full Text]

				V. Bousson, J.-L. Moretti, P. Weinmann, N. Safi, F. Tamgac, C. Groiselle, V. de Beco, Y. Hillali, D. Valeyre, and J.-L. Breau Assessment of Malignancy in Pulmonary Lesions: FDG Dual-Head Coincidence Gamma Camera Imaging in Association with Serum Tumor Marker Measurement J. Nucl. Med., November 1, 2000; 41(11): 1801 - 1807. [Abstract] [Full Text] [PDF]

				S. T. Mastin, W. E. Drane, E. M. Harman, J. J. Fenton, and L. Quesenberry FDG SPECT in Patients With Lung Masses Chest, April 1, 1999; 115(4): 1012 - 1017. [Abstract] [Full Text] [PDF]

				J. E. Udelson Steps Forward in the Assessment of Myocardial Viability in Left Ventricular Dysfunction Circulation, March 10, 1998; 97(9): 833 - 838. [Full Text] [PDF]

				G. Srinivasan, A. N. Kitsiou, S. L. Bacharach, M. L. Bartlett, C. Miller-Davis, and V. Dilsizian [18F]Fluorodeoxyglucose Single Photon Emission Computed Tomography : Can It Replace PET and Thallium SPECT for the Assessment of Myocardial Viability? Circulation, March 10, 1998; 97(9): 843 - 850. [Abstract] [Full Text] [PDF]